查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1684460

大腸直腸篩檢市場：全球產業分析、市場規模、佔有率、成長、趨勢和未來預測（2025-2032）

Colon Screening Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 181 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球大腸直腸篩檢市場的綜合報告。該報告對市場促進因素、趨勢、機會、促進因素和挑戰等關鍵市場動態進行了全面評估，並對市場結構提供了詳細的見解。本研究報告提供獨家資料和統計數據，概述了 2025 年至 2032 年全球結直腸篩檢市場的預期成長軌跡。

關鍵見解

  • 大腸直腸篩檢市場規模（2025年）：187億美元
  • 市場規模預測（以金額為準，2032年）：244.5億美元
  • 全球市場成長率（2025-2032年複合年成長率）：3.9%

大腸直腸篩檢市場：分析範圍

大腸篩檢在結腸癌的早期發現和預防中起著重要作用。大腸鏡檢查、糞便檢查和影像技術等篩檢方法有助於識別癌前息肉和早期惡性腫瘤，顯著改善患者的預後。大腸直腸篩檢市場服務於醫院、診斷檢測中心、門診手術中心和家庭醫療保健機構，提供各種篩檢技術，包括糞便免疫化學檢查(FIT)、糞便 DNA 檢測、乙狀結腸鏡檢查和 CT 結腸造影。市場成長的動力包括結直腸癌盛行率的上升、人們對早期發現益處的認知不斷提高以及篩檢技術的進步提高了準確性和可及性。

市場成長動力：

全球大腸直腸篩檢市場受到幾個關鍵因素的推動，包括飲食習慣的改變、人口老化以及久坐生活方式導致的大腸癌負擔的增加。政府推廣的定期篩檢計劃和優惠的報銷政策將進一步加速市場擴張。人工智慧 (AI) 輔助大腸鏡檢查、液態切片測試和非侵入性篩檢解決方案等技術進步將提高診斷準確性和患者依從性。此外，套件的日益普及為市場成長套件了新的途徑，特別是在醫療設施有限的地區。

市場限制：

儘管成長前景看好，但結直腸篩檢市場面臨著高檢測成本、低收入地區篩檢機會有限以及患者因侵入性檢測方法而不願接受篩檢等挑戰。此外，新篩檢技術的監管障礙和嚴格的核准流程也對製造商進入市場構成了障礙。此外，不同人口群體的意識和篩檢接受度的差異也影響整體市場滲透率。應對這些挑戰需要醫療保健提供者、政府和行業相關人員的共同努力，以提高篩檢的可負擔性、教育性和可近性。

市場機會：

在技​​術創新、策略夥伴關係和不斷擴大的醫療保健基礎設施的推動下，結直腸篩檢市場提供了巨大的成長機會。人工智慧在診斷成像中的整合、用於非侵入性早期檢測的液態切片的開發以及家庭篩檢套件的進步正在為市場參與者開闢新的領域。遠端醫療和數位健康平台可以進一步促進患者參與和後續護理，提高篩檢依從性。此外，對癌症研究和早期檢測舉措的資金增加為產品開發和市場發展創造了有利的環境。投資於具有成本效益且準確的篩選解決方案的公司將在這個不斷發展的市場中獲得競爭優勢。

本報告回答的關鍵問題

  • 推動全球大腸直腸篩檢市場成長的關鍵因素有哪些？
  • 哪些篩檢技術和方法在不同的醫療保健環境中獲得最多支援？
  • 科技進步如何改變大腸直腸篩檢市場的競爭格局？
  • 哪些主要企業正在為大腸直腸篩檢市場做出貢獻？他們採用什麼策略來維持市場相關性？
  • 全球大腸直腸篩檢市場的新興趨勢和未來前景如何？

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
    • 任務
    • 主要趨勢
  • 宏觀經濟因素
    • 全球產業展望
    • 全球GDP成長前景
  • COVID-19影響分析
  • 預測因子：相關性和影響力

第3章 增值洞察

  • 監管狀況
  • 產品採用分析
  • 價值鏈分析
  • 重大交易及合併
  • PESTLE分析
  • 波特五力分析

第4章全球大腸直腸篩檢市場展望

  • 主要亮點
    • 市場規模及與前一年同期比較率（十億美元）
    • 絕對的商機
  • 市場規模分析及預測（十億美元）
    • 歷史市場規模分析（十億美元，2019-2024）
    • 當前市場規模分析與預測（十億美元，2025-2032）
  • 全球大腸直腸篩檢市場展望（按篩檢類型）
    • 簡介/主要發現
    • 按篩檢類型分類的歷史市場規模分析（十億美元，2019-2024 年）
    • 按篩檢類型分類的當前市場規模分析和預測（十億美元，2025 年至 2032 年）
      • 糞便檢驗
        • 糞便免疫化學檢查（FIT）
        • 癒創木酚大便潛血試驗（gFOBT）
        • 其他
      • 大腸鏡檢查
      • 軟性乙狀結腸鏡檢查
      • 膠囊內視鏡檢查
      • 其他
    • 依篩檢類型進行市場吸引力分析
  • 全球大腸直腸篩檢市場展望（依產品類型）
    • 簡介/主要發現
    • 按產品類型分類的歷史市場規模分析（十億美元，2019-2024 年）
    • 目前市場規模分析及依產品類型預測（十億美元，2025-2032）
      • 內視鏡檢查
      • CT掃描儀
      • 膠囊內視鏡檢查
      • 檢測套件和試劑
      • 其他
    • 市場吸引力分析：按產品類型
  • 全球大腸直腸篩檢市場前景（按最終用戶）
    • 簡介/主要發現
    • 按最終用戶分類的歷史市場規模分析（十億美元，2019-2024 年）
    • 目前市場規模分析及最終用戶預測（十億美元，2025-2032）
      • 醫院
      • 診斷和影像中心
      • 研究和學術機構
      • 其他
    • 最終用戶的市場吸引力分析

5. 全球大腸直腸篩檢市場（按地區）展望

  • 主要亮點
  • 按地區分類的歷史市場規模分析（十億美元，2019-2024 年）
  • 目前市場規模分析及各地區預測（十億美元，2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

6. 北美大腸直腸篩檢市場展望

7. 歐洲大腸直腸篩檢市場展望

第8章東亞結直腸篩檢市場展望

9. 南亞和大洋洲結直腸篩檢市場展望

10. 拉丁美洲結直腸篩檢市場展望

第 11 章中東和非洲結直腸篩檢市場展望

第12章競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競爭強度圖：按市場
    • 競爭儀錶板
  • 公司簡介（詳情：概述、財務狀況、策略、最新發展）
    • Olympus Corporation
    • PENTAX Medical（Hoya Corporation）
    • FUJIFILM Holdings Corporation
    • Medtronic
    • Ambu A/S
    • Baxter（Hillrom &Welch Allyn）
    • EndoFresh
    • （Daichuan medical）
    • Bracco
    • Varay Laborix
    • QuidelOrtho Corporation
    • Novigenix SA
    • Guardant Health, Inc.
    • Mainz Biomed NV
    • Eiken Chemical Co., Ltd.

第13章 附錄

  • 分析方法
  • 分析前提條件
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP35162

Persistence Market Research has recently released a comprehensive report on the worldwide market for colon screening. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global colon screening market from 2025 to 2032.

Key Insights:

  • Colon Screening Market Size (2025E): US$ 18.7 Bn
  • Projected Market Value (2032F): US$ 24.45 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 3.9%

Colon Screening Market - Report Scope:

Colon screening plays a crucial role in the early detection and prevention of colorectal cancer, one of the leading causes of cancer-related deaths worldwide. Screening methods such as colonoscopy, stool-based tests, and imaging techniques help identify precancerous polyps and early-stage malignancies, significantly improving patient outcomes. The colon screening market serves hospitals, diagnostic laboratories, ambulatory surgical centers, and home healthcare settings, offering a range of screening technologies, including fecal immunochemical tests (FIT), stool DNA tests, sigmoidoscopy, and CT colonography. Market growth is driven by the rising prevalence of colorectal cancer, increasing awareness of early detection benefits, and advancements in screening technologies that enhance accuracy and accessibility.

Market Growth Drivers:

The global colon screening market is propelled by several key factors, including the growing burden of colorectal cancer due to changing dietary habits, aging populations, and sedentary lifestyles. Government initiatives promoting routine screening programs and favorable reimbursement policies further accelerate market expansion. Technological advancements, such as artificial intelligence (AI)-assisted colonoscopy, liquid biopsy tests, and non-invasive screening solutions, enhance diagnostic precision and patient compliance. Additionally, the increasing adoption of home-based and self-administered screening kits provides new avenues for market growth, particularly in regions with limited access to healthcare facilities.

Market Restraints:

Despite promising growth prospects, the colon screening market faces challenges related to high procedure costs, limited access to screening in low-income regions, and patient reluctance due to invasive test methods. Regulatory hurdles and stringent approval processes for new screening technologies also pose market entry barriers for manufacturers. Furthermore, disparities in awareness and screening adherence rates across different demographic groups impact overall market penetration. Addressing these challenges requires collaborative efforts from healthcare providers, governments, and industry stakeholders to enhance screening affordability, education, and accessibility.

Market Opportunities:

The colon screening market presents significant growth opportunities driven by technological innovations, strategic partnerships, and expanding healthcare infrastructure. The integration of AI in diagnostic imaging, liquid biopsy development for non-invasive early detection, and advancements in at-home screening kits open new frontiers for market players. Telemedicine and digital health platforms further facilitate patient engagement and follow-up care, improving screening adherence rates. Additionally, increased funding for cancer research and early detection initiatives creates a favorable landscape for product development and market expansion. Companies investing in cost-effective, high-accuracy screening solutions stand to gain a competitive advantage in this evolving market.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the colon screening market globally?
  • Which screening technologies and methods are gaining the most traction across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the colon screening market?
  • Who are the key players contributing to the colon screening market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global colon screening market?

Competitive Intelligence and Business Strategy:

Leading players in the global colon screening market, including Exact Sciences Corporation, Abbott Laboratories, Siemens Healthineers, and Olympus Corporation, focus on innovation, regulatory approvals, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop next-generation screening technologies, such as AI-driven colonoscopy tools, liquid biopsy solutions, and enhanced stool-based tests, catering to diverse patient needs. Partnerships with healthcare providers, insurance companies, and diagnostic laboratories facilitate market access and promote screening adoption. Additionally, initiatives aimed at increasing patient awareness, physician training, and government collaborations further strengthen market penetration.

Key Companies Profiled:

  • Exact Sciences Corporation
  • Abbott Laboratories
  • Siemens Healthineers
  • Olympus Corporation
  • Medtronic Plc
  • Quest Diagnostics Incorporated
  • Epigenomics AG
  • Natera, Inc.
  • Guardant Health, Inc.
  • Eiken Chemical Co., Ltd.

Colon Screening Industry Segmentation

By Screening Type

  • Stool-Based Tests
  • Colonoscopy
  • Flexible Sigmoidoscopy
  • Capsule Endoscopy

By Product Type

  • Endoscopes
  • CT Scanners
  • Capsule Endoscopes
  • Test Kits & Reagents

By End User

  • Hopitals
  • Diagnostic & Imaging Centers
  • Research & Academic Institutions

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Colon Screening Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Regulatory Landscape
  • 3.2. Product Adoption Analysis
  • 3.3. Value Chain Analysis
  • 3.4. Key Deals and Mergers
  • 3.5. PESTLE Analysis
  • 3.6. Porter's Five Force Analysis

4. Global Colon Screening Market Outlook:

  • 4.1. Key Highlights
    • 4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
    • 4.1.2. Absolute $ Opportunity
  • 4.2. Market Size (US$ Bn) Analysis and Forecast
    • 4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2024
    • 4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2025-2032
  • 4.3. Global Colon Screening Market Outlook: Screening Type
    • 4.3.1. Introduction / Key Findings
    • 4.3.2. Historical Market Size (US$ Bn) Analysis, By Screening Type,2019-2024
    • 4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
      • 4.3.3.1. Stool-Based Tests
        • 4.3.3.1.1. Fecal Immunochemical Test (FIT)
        • 4.3.3.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
        • 4.3.3.1.3. Others
      • 4.3.3.2. Colonoscopy
      • 4.3.3.3. Flexible Sigmoidoscopy
      • 4.3.3.4. Capsule Endoscopy
      • 4.3.3.5. Others
    • 4.3.4. Market Attractiveness Analysis: Screening Type
  • 4.4. Global Colon Screening Market Outlook: Product Type
    • 4.4.1. Introduction / Key Findings
    • 4.4.2. Historical Market Size (US$ Bn) Analysis, By Product Type,2019-2024
    • 4.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      • 4.4.3.1. Endoscopes
      • 4.4.3.2. CT Scanners
      • 4.4.3.3. Capsule Endoscopes
      • 4.4.3.4. Test Kits & Reagents
      • 4.4.3.5. Others
    • 4.4.4. Market Attractiveness Analysis: Product Type
  • 4.5. Global Colon Screening Market Outlook: End User
    • 4.5.1. Introduction / Key Findings
    • 4.5.2. Historical Market Size (US$ Bn) Analysis, By End User,2019-2024
    • 4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
      • 4.5.3.1. Hospitals
      • 4.5.3.2. Diagnostic & Imaging Centers
      • 4.5.3.3. Research & Academic Institutions
      • 4.5.3.4. Others
    • 4.5.4. Market Attractiveness Analysis: End User

5. Global Colon Screening Market Outlook: Region

  • 5.1. Key Highlights
  • 5.2. Historical Market Size (US$ Bn) Analysis, By Region,2019-2024
  • 5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. East Asia
    • 5.3.4. South Asia and Oceania
    • 5.3.5. Latin America
    • 5.3.6. Middle East & Africa
  • 5.4. Market Attractiveness Analysis: Region

6. North America Colon Screening Market Outlook:

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 6.2.1. By Country
    • 6.2.2. By Screening Type
    • 6.2.3. By Product Type
    • 6.2.4. By End User
  • 6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 6.3.1. U.S.
    • 6.3.2. Canada
  • 6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 6.4.1. Stool-Based Tests
      • 6.4.1.1. Fecal Immunochemical Test (FIT)
      • 6.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 6.4.1.3. Others
    • 6.4.2. Colonoscopy
    • 6.4.3. Flexible Sigmoidoscopy
    • 6.4.4. Capsule Endoscopy
    • 6.4.5. Others
  • 6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 6.5.1. Endoscopes
    • 6.5.2. CT Scanners
    • 6.5.3. Capsule Endoscopes
    • 6.5.4. Test Kits & Reagents
    • 6.5.5. Others
  • 6.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 6.6.1. Hospitals
    • 6.6.2. Diagnostic & Imaging Centers
    • 6.6.3. Research & Academic Institutions
    • 6.6.4. Others
  • 6.7. Market Attractiveness Analysis

7. Europe Colon Screening Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Screening Type
    • 7.2.3. By Product Type
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. Germany
    • 7.3.2. France
    • 7.3.3. U.K.
    • 7.3.4. Italy
    • 7.3.5. Spain
    • 7.3.6. Russia
    • 7.3.7. Turkey
    • 7.3.8. Rest of Europe
  • 7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 7.4.1. Stool-Based Tests
      • 7.4.1.1. Fecal Immunochemical Test (FIT)
      • 7.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 7.4.1.3. Others
    • 7.4.2. Colonoscopy
    • 7.4.3. Flexible Sigmoidoscopy
    • 7.4.4. Capsule Endoscopy
    • 7.4.5. Others
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 7.5.1. Endoscopes
    • 7.5.2. CT Scanners
    • 7.5.3. Capsule Endoscopes
    • 7.5.4. Test Kits & Reagents
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Diagnostic & Imaging Centers
    • 7.6.3. Research & Academic Institutions
    • 7.6.4. Others
  • 7.7. Market Attractiveness Analysis

8. East Asia Colon Screening Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Screening Type
    • 8.2.3. By Product Type
    • 8.2.4. By End User
  • 8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. China
    • 8.3.2. Japan
    • 8.3.3. South Korea
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 8.4.1. Stool-Based Tests
      • 8.4.1.1. Fecal Immunochemical Test (FIT)
      • 8.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 8.4.1.3. Others
    • 8.4.2. Colonoscopy
    • 8.4.3. Flexible Sigmoidoscopy
    • 8.4.4. Capsule Endoscopy
    • 8.4.5. Others
  • 8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 8.5.1. Endoscopes
    • 8.5.2. CT Scanners
    • 8.5.3. Capsule Endoscopes
    • 8.5.4. Test Kits & Reagents
    • 8.5.5. Others
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Diagnostic & Imaging Centers
    • 8.6.3. Research & Academic Institutions
    • 8.6.4. Others
  • 8.7. Market Attractiveness Analysis

9. South Asia & Oceania Colon Screening Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Screening Type
    • 9.2.3. By Product Type
    • 9.2.4. By End User
  • 9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. India
    • 9.3.2. Southeast Asia
    • 9.3.3. ANZ
    • 9.3.4. Rest of South Asia & Oceania
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 9.4.1. Stool-Based Tests
      • 9.4.1.1. Fecal Immunochemical Test (FIT)
      • 9.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 9.4.1.3. Others
    • 9.4.2. Colonoscopy
    • 9.4.3. Flexible Sigmoidoscopy
    • 9.4.4. Capsule Endoscopy
    • 9.4.5. Others
  • 9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 9.5.1. Endoscopes
    • 9.5.2. CT Scanners
    • 9.5.3. Capsule Endoscopes
    • 9.5.4. Test Kits & Reagents
    • 9.5.5. Others
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Diagnostic & Imaging Centers
    • 9.6.3. Research & Academic Institutions
    • 9.6.4. Others
  • 9.7. Market Attractiveness Analysis

10. Latin America Colon Screening Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Screening Type
    • 10.2.3. By Product Type
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. Brazil
    • 10.3.2. Mexico
    • 10.3.3. Rest of Latin America
  • 10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 10.4.1. Stool-Based Tests
      • 10.4.1.1. Fecal Immunochemical Test (FIT)
      • 10.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 10.4.1.3. Others
    • 10.4.2. Colonoscopy
    • 10.4.3. Flexible Sigmoidoscopy
    • 10.4.4. Capsule Endoscopy
    • 10.4.5. Others
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 10.5.1. Endoscopes
    • 10.5.2. CT Scanners
    • 10.5.3. Capsule Endoscopes
    • 10.5.4. Test Kits & Reagents
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Diagnostic & Imaging Centers
    • 10.6.3. Research & Academic Institutions
    • 10.6.4. Others
  • 10.7. Market Attractiveness Analysis

11. Middle East & Africa Colon Screening Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Market,2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Screening Type
    • 11.2.3. By Product Type
    • 11.2.4. By End User
  • 11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. GCC Countries
    • 11.3.2. Egypt
    • 11.3.3. South Africa
    • 11.3.4. Northern Africa
    • 11.3.5. Rest of Middle East & Africa
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Screening Type, 2025-2032
    • 11.4.1. Stool-Based Tests
      • 11.4.1.1. Fecal Immunochemical Test (FIT)
      • 11.4.1.2. Guaiac-Based Fecal Occult Blood Test (gFOBT)
      • 11.4.1.3. Others
    • 11.4.2. Colonoscopy
    • 11.4.3. Flexible Sigmoidoscopy
    • 11.4.4. Capsule Endoscopy
    • 11.4.5. Others
  • 11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
    • 11.5.1. Endoscopes
    • 11.5.2. CT Scanners
    • 11.5.3. Capsule Endoscopes
    • 11.5.4. Test Kits & Reagents
    • 11.5.5. Others
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Diagnostic & Imaging Centers
    • 11.6.3. Research & Academic Institutions
    • 11.6.4. Others
  • 11.7. Market Attractiveness Analysis

12. Competition Landscape

  • 12.1. Market Share Analysis, 2025
  • 12.2. Market Structure
    • 12.2.1. Competition Intensity Mapping By Market
    • 12.2.2. Competition Dashboard
  • 12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 12.3.1. Olympus Corporation
      • 12.3.1.1. Overview
      • 12.3.1.2. Segments and Products
      • 12.3.1.3. Key Financials
      • 12.3.1.4. Market Developments
      • 12.3.1.5. Market Strategy
    • 12.3.2. PENTAX Medical (Hoya Corporation)
    • 12.3.3. FUJIFILM Holdings Corporation
    • 12.3.4. Medtronic
    • 12.3.5. Ambu A/S
    • 12.3.6. Baxter (Hillrom & Welch Allyn)
    • 12.3.7. EndoFresh
    • 12.3.8. (Daichuan medical)
    • 12.3.9. Bracco
    • 12.3.10. Varay Laborix
    • 12.3.11. QuidelOrtho Corporation
    • 12.3.12. Novigenix SA
    • 12.3.13. Guardant Health, Inc.
    • 12.3.14. Mainz Biomed N.V.
    • 12.3.15. Eiken Chemical Co., Ltd.

13. Appendix

  • 13.1. Research Methodology
  • 13.2. Research Assumptions
  • 13.3. Acronyms and Abbreviations